SECREFLO
LOE Approachingsecretin synthetic porcine
NDAINTRAVENOUSFOR SOLUTION
Approved
Apr 2002
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
SECREFLO (secretin synthetic porcine) is mechanism of action 12. First approved in 2002.
Drug data last refreshed 23h ago · AI intelligence enriched 4d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SECREFLO is a synthetic porcine secretin injection administered intravenously to stimulate pancreatic ductal secretion for diagnostic purposes. It binds to secretin receptors on pancreatic duct cells, opening CFTR channels to trigger bicarbonate-rich pancreatic fluid secretion. The drug mimics the natural hormone secretin released during normal digestive processes.
LOE Approaching
Declining market opportunity with moderate competitive pressure (30% intensity) suggests team optimization and transition planning are underway.
Mechanism of Action
Mechanism of Action 12.1 Mechanism of Action The primary action of ChiRhoStim is to stimulate pancreatic ductal cells to secrete pancreas fluid in large volumes that contain bicarbonate. Secretin is a hormone that is normally released from the duodenum upon exposure of the proximal intestinal lumen…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on SECREFLO offers limited career growth due to minimal linked job postings (0) and LOE-approaching lifecycle stage. This is a mature diagnostic asset best suited for professionals seeking stability in a niche specialty space or those transitioning to adjacent portfolio products.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.